1. Home
  2. SIBN vs AVXL Comparison

SIBN vs AVXL Comparison

Compare SIBN & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SIBN
  • AVXL
  • Stock Information
  • Founded
  • SIBN 2008
  • AVXL 2004
  • Country
  • SIBN United States
  • AVXL United States
  • Employees
  • SIBN N/A
  • AVXL N/A
  • Industry
  • SIBN Medical/Dental Instruments
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SIBN Health Care
  • AVXL Health Care
  • Exchange
  • SIBN Nasdaq
  • AVXL Nasdaq
  • Market Cap
  • SIBN 805.4M
  • AVXL 710.3M
  • IPO Year
  • SIBN 2018
  • AVXL N/A
  • Fundamental
  • Price
  • SIBN $16.39
  • AVXL $9.09
  • Analyst Decision
  • SIBN Strong Buy
  • AVXL Strong Buy
  • Analyst Count
  • SIBN 5
  • AVXL 2
  • Target Price
  • SIBN $24.40
  • AVXL $44.00
  • AVG Volume (30 Days)
  • SIBN 451.8K
  • AVXL 768.8K
  • Earning Date
  • SIBN 08-04-2025
  • AVXL 08-05-2025
  • Dividend Yield
  • SIBN N/A
  • AVXL N/A
  • EPS Growth
  • SIBN N/A
  • AVXL N/A
  • EPS
  • SIBN N/A
  • AVXL N/A
  • Revenue
  • SIBN $176,601,000.00
  • AVXL N/A
  • Revenue This Year
  • SIBN $19.48
  • AVXL N/A
  • Revenue Next Year
  • SIBN $16.86
  • AVXL N/A
  • P/E Ratio
  • SIBN N/A
  • AVXL N/A
  • Revenue Growth
  • SIBN 22.60
  • AVXL N/A
  • 52 Week Low
  • SIBN $11.70
  • AVXL $3.76
  • 52 Week High
  • SIBN $20.05
  • AVXL $14.44
  • Technical
  • Relative Strength Index (RSI)
  • SIBN 36.27
  • AVXL 64.24
  • Support Level
  • SIBN $17.35
  • AVXL $7.97
  • Resistance Level
  • SIBN $19.24
  • AVXL $9.35
  • Average True Range (ATR)
  • SIBN 0.61
  • AVXL 0.38
  • MACD
  • SIBN -0.40
  • AVXL 0.18
  • Stochastic Oscillator
  • SIBN 2.00
  • AVXL 86.10

About SIBN SI-BONE Inc.

SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

Share on Social Networks: